MK-6837 is under clinical development by Merck and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR) ...

Bempikibart (ADX-914) is under development for the treatment of atopic dermatitis and alopecia areata. It is administered through subcutaneous route and acts by targeting interleukin-7 receptor (IL-7R ...

Copper demand is expected to stay red-hot, according to Jorge Cantallopts, an executive director at the Center for Copper and ...

VANCOUVER, British Columbia, Dec. 31, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in next generation ...

The success or failure of this transition hinges on the results of ... the target is “3 percent or higher.” “To ensure a phase change in the domestic economy and society, we will aim for ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Liverpool’s new manager has openly acknowledged that his playing style is not worlds apart from his predecessor, Jurgen Klopp, which has made the transition from one to the other far smoother.

Pharmaceutical and biotech stocks may find it tough to outperform the market in the months ahead. That is the view of UBS ...

The World Bank in its latest report has highly appreciated the policies and the high tech moves of the Vietnam Government and ...

The global semiconductor industry is making headlines, fuelled by surging demand for electronic devices and groundbreaking ...

Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF; FRA: CM5R) ("Troilus” or the "Company”), is pleased to provide a recap of its ...

Brent is also at the heart of a number of proposed changes by Transport for London (TfL), including the creation of a new ...